ÂÜÀòÂÒÂ×

Mr. Kirsch is Director and Senior Advisor, as well as global head of medical devices and diagnostics, of GCA Global, LLC, a global investment banking firm. Mr. Kirsch has been focused on both M&A and Capital Markets transactions within the healthcare industry for the past 20 years. Mr. Kirsch’s experience spans advising both public and private companies with extensive knowledge of cross border transactions between the U.S. and Asia. Prior to joining GCA Global, he was a executive vice president, head of research at Vector Securities. Previously, Mr. Kirsch was president of Natwest Securities Limited, a foreign owned investment bank. Mr. Kirsch began his career on Wall Street at Drexel Burnham Lambert and eventually became head of the Equity Division and a member of the firm’s Executive Committee. He serves as Chairman of the Board of Directors at Aralez, Inc. a public biopharmaceutical company where he is also Chairman of the Audit Committee. Mr. Kirsch earned a B.S. in Finance at the University of Rhode Island and an MBA from The City University of New York.